BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2015 8:56:00 PM | Browse: 1041 | Download: 1792
Publication Name World Journal of Diabetes
Manuscript ID 19194
Country/Territory Japan
Received
2015-05-01 14:23
Peer-Review Started
2015-05-03 22:21
To Make the First Decision
2015-06-18 16:13
Return for Revision
2015-06-24 15:47
Revised
2015-07-06 00:00
Second Decision
2015-07-17 08:32
Accepted by Journal Editor-in-Chief
2015-07-17 23:34
Accepted by Company Editor-in-Chief
2015-07-27 17:19
Articles in Press
2015-07-27 17:19
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-08-21 18:19
Publish the Manuscript Online
2015-08-26 20:56
ISSN 1948-9358 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Editorial
Article Title Effect of proton pump inhibitors on glycemic control in patients with diabetes
Manuscript Source Invited Manuscript
All Author List Kohzo Takebayashi and Toshihiko Inukai
Funding Agency and Grant Number
Corresponding Author Kohzo Takebayashi, MD, Department of Internal Medicine, Dokkyo Medical University Koshigaya Hospital, 2-1-50 Minamikoshigaya, Koshigaya, Saitama 343-8555, Japan. takeb@gmail.plala.or.jp
Key Words Gastrin; Proton pump inhibitors; Glycemic control; Type 2 diabetes
Core Tip Recently, it is reported that gastrin may improve glucose tolerance mainly by the promotion of pancreatic cell neogenesis. Proton pump inhibitors (PPIs) are wildly used clinically for the treatment such as gastric ulcers, and it is known that PPIs indirectly elevate serum gastrin levels. Recent evidence has showed the beneficial effect of PPIs on glycemic control especially in patients with type 2 diabetes, probably via the elevation of serum gastrin levels. Therefore, PPIs may have the potential to be candidates for a new approach in the treatment of diabetes.
Publish Date 2015-08-26 20:56
Citation Takebayashi K, Inukai T. Effect of proton pump inhibitors on glycemic control in patients with diabetes. World J Diabetes 2015; 6(10): 1122-1131
URL http://www.wjgnet.com/1948-9358/full/v6/i10/1122.htm
DOI http://dx.doi.org/10.4239/wjd.v6.i10.1122
Full Article (PDF) WJD-6-1122.pdf
Full Article (Word) WJD-6-1122.doc
Manuscript File 19194-Review.doc
Answering Reviewers 19194-Answering reviewers.pdf
Audio Core Tip 19194-Audio core tip.wav
Conflict-of-Interest Disclosure Form 19194-Conflict-of-interest statement.pdf
Copyright License Agreement 19194-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 19194-Language certificate.pdf
Peer-review Report 19194-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 19194-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 19194-Scientific misconduct check.pdf
Scientific Editor Work List 19194-Scientific editor work list.pdf